MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Acetazolamide for Injection, USP (Mylan USA) | |
New | Alphaclav Duo Viatris, Alphaclav Duo Forte Viatris | |
New | APOHealth Sinus & Pain Relief | |
New | APO-Levothyroxine | |
New | APX-Perindopril Arginine | |
New | APX-Perindopril Arginine/ Amlodipine | |
New | Bendamustine Sandoz | |
New | Cisatracurium Accord | |
New | Daptomycin Lupin | |
New | Doxepin Hydrochloride Capsules, USP (Amneal) | |
New | GlucaGen HypoKit (Germany) (Link) | |
New | GlucaGen HypoKit (Germany) (Medsurge) | |
New | GlucaGen Hypokit (Italy) | |
New | GlucaGen HypoKit (Switzerland) | |
New | Glucagon Emergency Kit for Low Blood Sugar (Amphastar Pharmaceuticals, USA) | |
New | Levothyroxine Lup | |
New | Lidocaine Accord | |
New | Meloxicam Viatris | |
New | Nicabate Mini Lozenges (New Formulation) | |
New | Posaconazole Suspension ARX | |
New | Rilast Rapihaler | |
New | Sandoz Estradiol Derm (Canada) | |
New | Ultra Nature Immune Defence | |
New | Ultra Nature Iron Advanced | |
New | Ultra Nature Joint Repair & Pain Relief | |
New | Ultra Nature Liver Detox & Digestive Support | |
New | Ultra Nature Memory & Cognition Boost | |
New | Ultra Nature Skin Anti-Ageing + Energy | |
Revised | Acamprosate Viatris | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Actrapid Preparations | TGA Date, TGA Date, TGA Date |
Revised | Adalase | Description, Indications |
Revised | Adcirca | Nature and Contents of Container |
Revised | Adriamycin | Nature and Contents of Container, Physicochemical Properties, Qualitative and Quantitative Composition |
Revised | Anastrozole-GH | Adverse Effects (Undesirable Effects) |
Revised | APO-Amisulpride | TGA Date |
Revised | APO-Amlodipine | Nature and Contents of Container |
Revised | APO-Amoxycillin Capsules | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Amoxycillin Powder for Suspension | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Citalopram | Adverse Effects (Undesirable Effects) |
Revised | APO-Donepezil | Sponsor |
Revised | APO-Irbesartan HCTZ | Nature and Contents of Container |
Revised | APO-Tranexamic Acid | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Venlafaxine XR | TGA Date |
Revised | APX-Amoxicillin/Clavulanic Acid | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APX-Pantoprazole | Product Name change |
Revised | APX-Rosuvastatin | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Ardix Lurasidone | TGA Date |
Revised | Aurorix | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Azithromycin Sandoz | Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Bexsero | Dose and Method of Administration, Nature and Contents of Container, Shelf Life, Special Warnings and Precautions for Use |
Revised | Biktarvy Bottle | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Biltricide | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | BioFem | Description, Indications, Precautions |
Revised | Blooms the Chemist Irbesartan | TGA Date |
Revised | Blooms the Chemist Irbesartan HCTZ | TGA Date |
Revised | Blooms the Chemist Rosuvastatin | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Blooms the Chemist Venlafaxine XR | TGA Date |
Revised | Boostrix | Dose and Method of Administration, Nature and Contents of Container, Special Precautions for Storage |
Revised | Boostrix-IPV | Dose and Method of Administration, Nature and Contents of Container, Special Precautions for Storage |
Revised | Brooke | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Brooklynn | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Bupredermal | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Cabazitaxel Accord | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Campral | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Candesan Combi | TGA Date |
Revised | Cardizem | Overdose |
Revised | Cardizem CD | Overdose |
Revised | Cervarix | Dose and Method of Administration, Nature and Contents of Container |
Revised | Cialis | Nature and Contents of Container |
Revised | Cilatil | Nature and Contents of Container |
Revised | Clobex | TGA Date |
Revised | Clozaril | Nature and Contents of Container |
Revised | Codalgin Forte | Pharmaceutical Form |
Revised | CogniCare | Product Name change |
Revised | Comirnaty | Therapeutic Indications |
Revised | Comirnaty (Tris/Sucrose Presentation) | Therapeutic Indications |
Revised | Crosuva | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Cyclogest | TGA Date |
Revised | DBL Aciclovir Intravenous Infusion | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | DBL Aminophylline Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | DBL Docetaxel Concentrated Injection | Fertility, Pregnancy and Lactation |
Revised | DBL Methotrexate Injection | Adverse Effects (Undesirable Effects) |
Revised | Denpax | Nature and Contents of Container, Overdose |
Revised | Deptran | Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Dexamethasone Viatris | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Diflucan One | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dilatrend | Special Warnings and Precautions for Use |
Revised | Dilaudid | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Dilaudid, Dilaudid-HP injections | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Diltiazem Sandoz CD | Overdose |
Revised | Diphereline | Special Warnings and Precautions for Use |
Revised | D-Penamine | Adverse Effects (Undesirable Effects) |
Revised | Dupixent | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Elaxine SR | TGA Date |
Revised | Eleanor 150/30 ED | TGA Date |
Revised | E-Mycin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Engerix-B Vaccine | Dose and Method of Administration, Nature and Contents of Container |
Revised | Enlafax-XR | TGA Date |
Revised | Entyvio | Nature and Contents of Container, Special Precautions for Storage |
Revised | Epiduo | TGA Date |
Revised | Epidyolex | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use |
Revised | Estelle-35 ED | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Eumovate | TGA Date |
Revised | Evocair MDI | Nature and Contents of Container, Pharmaceutical Form |
Revised | Ezetimibe/Simvastatin Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Fasenra | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Ferinject | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Flixonase Allergy & Hayfever 24 Hour | TGA Date |
Revised | Flomaxtra | Adverse Effects (Undesirable Effects) |
Revised | Flucelvax Quad | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | FML | Adverse Effects (Undesirable Effects) |
Revised | Forxiga | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Therapeutic Indications |
Revised | Gelofusine | Nature and Contents of Container, Physicochemical Properties |
Revised | Havrix 1440, Havrix Junior (Preservative Free) | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container |
Revised | Hydrocortisone Juno | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Imfinzi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Indocid | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Infanrix | Dose and Method of Administration, Nature and Contents of Container |
Revised | Infanrix Hexa (thiomersal free) | Dose and Method of Administration, Nature and Contents of Container |
Revised | Infanrix-IPV | Dose and Method of Administration, Nature and Contents of Container |
Revised | Ionolyte | TGA Date |
Revised | Keflor | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Keflor CD | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Kerendia | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Kesimpta | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Kuvan | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Latuda | TGA Date |
Revised | Levetiracetam Viatris | Product Name change |
Revised | Lexapro | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Lynparza Tablets | Dose and Method of Administration |
Revised | Madeline | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor |
Revised | Marcain, Marcain with Adrenaline | Special Precautions for Storage |
Revised | Mayzent | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Mekinist | Dose and Method of Administration, Pharmacological Properties |
Revised | Methylphenidate XR ARX | Adverse Effects (Undesirable Effects) |
Revised | Methylphenidate-Teva XR | Adverse Effects (Undesirable Effects) |
Revised | Metopirone | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Metronidazole Juno | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Micronelle 20 ED | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Micronelle 30 ED | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Minax | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Mirvaso | TGA Date |
Revised | Mixtard Preparations | TGA Date, TGA Date, TGA Date |
Revised | Mozobil | Fertility, Pregnancy and Lactation |
Revised | MS-2 Step | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Name of Medicine, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | MultiBic | TGA Date |
Revised | Norspan | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Ogivri | TGA Date |
Revised | Ondansetron ODT Viatris | TGA Date |
Revised | Ovestin Cream | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ovestin Ovula | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ovestin Tablets | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | OxyContin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use |
Revised | OxyNorm | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | OxyNorm Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use |
Revised | Parapane Osteo | Nature and Contents of Container |
Revised | Paxam | List of Excipients |
Revised | Paxlovid | Pharmaceutical Form |
Revised | Pharmorubicin | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Phenobarb | TGA Date |
Revised | Piax Plus Aspirin | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Plegridy | TGA Date |
Revised | Plenvu | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Prednefrin Forte | Adverse Effects (Undesirable Effects) |
Revised | Pritor/Amlodipine | Overdose |
Revised | Protaphane Preparations | TGA Date, TGA Date, TGA Date |
Revised | Repreve | Adverse Effects (Undesirable Effects) |
Revised | Revatio | TGA Date |
Revised | Rinvoq | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Rivotril | TGA Date |
Revised | Rosuvastatin Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Rozlytrek | Adverse Effects (Undesirable Effects) |
Revised | Saxenda | Adverse Effects (Undesirable Effects) |
Revised | Sildatio PHT | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Simvastatin Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Solifenacin Dr. Reddy's | TGA Date |
Revised | Somidem | Adverse Effects (Undesirable Effects), Nature and Contents of Container |
Revised | Sporanox Capsules | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Sporanox Oral Solution | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Stilnox CR | Nature and Contents of Container |
Revised | Tafinlar | Pharmacological Properties |
Revised | Tecartus | Adverse Effects (Undesirable Effects) |
Revised | Tecfidera | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tobi, Tobi Podhaler | Special Warnings and Precautions for Use |
Revised | Topiramate Sandoz | Contraindications, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tramadol AN Injection | Adverse Effects (Undesirable Effects) |
Revised | Tranexamic Acid Lupin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Transiderm-Nitro | TGA Date |
Revised | Triprim | TGA Date |
Revised | Trodelvy | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Twinrix Preservative Free | Dose and Method of Administration, Nature and Contents of Container |
Revised | Twynsta | Overdose |
Revised | Tysabri | Dose and Method of Administration, Special Precautions for Storage |
Revised | Ultomiris 100 mg/mL | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ultra Nature Selituss Chesty Cough Syrup | Adverse Effects, Dosage and Administration, Interactions with Other Medicines, Precautions, Therapeutic Indications |
Revised | Valium | Pharmaceutical Form |
Revised | Varivax Refrigerated | Adverse Effects (Undesirable Effects) |
Revised | Vasocardol CD | Overdose |
Revised | Vasocardol Tablets | Overdose |
Revised | Voriconazole InterPharma | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Product Name change |
Revised | Vyvanse | Adverse Effects (Undesirable Effects) |
Revised | Vzole | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Yana | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Yelena | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Yonsa Mpred | TGA Date |
Revised | Zavedos | Nature and Contents of Container |
Revised | Zejula | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Zolgensma | Pharmacological Properties, Special Warnings and Precautions for Use |
Deleted | Alendronate Plus D3-DRLA | |
Deleted | Amclavox Duo 500/125, Amclavox Duo Forte 875/125 | |
Deleted | APO-Ziprasidone | |
Deleted | Arthrexin | |
Deleted | Ascabiol | |
Deleted | Cephalexin Capsules, USP (Ascend) | |
Deleted | DRN 4366 Technescan HDP | |
Deleted | Hydraderm | |
Deleted | Hydralazine Link | |
Deleted | Medco Ibuprofen 200 and Codeine Phosphate 12.8 | |
Deleted | Medco Paracetamol 500 and Codeine Phosphate 15 | |
Deleted | Medco Paracetamol 500, Codeine Phosphate 10 and Doxylamine Succinate 5.1 | |
Deleted | Neuro S | |
Deleted | Oxycodone BNM | |
Deleted | Rulide | |
Deleted | Sensipar | |
Deleted | Sovaldi | |
Deleted | Sulfamethoxazole and Trimethoprim Tablets, USP (Aurobindo) (Pro Pharma) | |
Deleted | TriGenex | |
Deleted | Verorab | |
Deleted | Zorac Cream |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au